These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19507085)

  • 21. [Improved therapeutic possibilities of age-related macular degeneration. The Danish Society of Ophthalmology].
    Hansen MH; Mortensen KK; Sjølie AK
    Ugeskr Laeger; 2003 Mar; 165(12):1249. PubMed ID: 12701299
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapeutic options in age-related exudative macular degeneration].
    Stanca HT
    Oftalmologia; 2007; 51(1):7-11. PubMed ID: 17605263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Asscociation of Ophthalmologists (BVA). Stand 15.10.2022].
    ; ;
    Klin Monbl Augenheilkd; 2023 Feb; 240(2):180-189. PubMed ID: 36812925
    [No Abstract]   [Full Text] [Related]  

  • 24. [Statement of the German Ophthalmological Society, the Retinological Society and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Situation August 2019].
    ; ;
    Ophthalmologe; 2020 Mar; 117(3):218-247. PubMed ID: 31932952
    [No Abstract]   [Full Text] [Related]  

  • 25. [AMD: Future therapies].
    Cohen SY; Girmens JF
    J Fr Ophtalmol; 2011 Sep; 34(7):498-501. PubMed ID: 21658792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rapidly evolving diagnosis and treatment of age-related macular degeneration.
    Optometry; 2009 Feb; 80(2):101-6. PubMed ID: 19195112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment and quality assurance of refractive surgical interventions by the DOG (German Society of Ophthalmology) and the BVA (Professional Association of German Ophthalmologists): Update January 2014].
    Kohnen T; Neuhann T; Knorz MC
    Ophthalmologe; 2014 Apr; 111(4):320-9. PubMed ID: 24756188
    [No Abstract]   [Full Text] [Related]  

  • 28. Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Association of German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-related macular degeneration : Status February 2020.
    ; ;
    Ophthalmologe; 2021 Jan; 118(Suppl 1):31-39. PubMed ID: 32728806
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
    Roth DB; Kulkarni KM; Walsman S; Modi A
    Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related macular degeneration: treating the whole patient.
    Tasman W; Rovner B
    Can J Ophthalmol; 2005 Jun; 40(3):389-91. PubMed ID: 15947809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adapted and standardised patient management in the treatment of neovascular AMD in the outpatient setting of a university eye hospital].
    Framme C; Wolf-Schnurrbusch UE; Lobsiger H; Bayer S; Wolf S
    Klin Monbl Augenheilkd; 2012 Aug; 229(8):812-21. PubMed ID: 22615063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the current state research into the management of age-related macular degeneration (AMD)(1).
    Leys A; Verougstraete C
    Bull Soc Belge Ophtalmol; 2001; (279):106-7. PubMed ID: 11344710
    [No Abstract]   [Full Text] [Related]  

  • 33. [Age-related macular degeneration. The Danish Society of Ophthalmology].
    la Cour MD; Larsen M
    Ugeskr Laeger; 2006 Mar; 168(12):1235. PubMed ID: 16571326
    [No Abstract]   [Full Text] [Related]  

  • 34. The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary.
    Chakravarthy U; Williams M;
    Eye (Lond); 2013 Dec; 27(12):1429-31. PubMed ID: 24158023
    [No Abstract]   [Full Text] [Related]  

  • 35. [Genetic aspects of age-related macular degeneration].
    Janik-Papis K; Zaraś M; Skłodowska A; Ulińska M; Borucka AI; Błasiak J
    Klin Oczna; 2009; 111(4-6):178-82. PubMed ID: 19673454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach of Turkish ophthalmologists to micronutrition in age-related macular degeneration.
    Muhammed Ş; Yüksel H; Şahin A; Cingü AK; Türkcü FM; Özkurt ZG; Çaça İ
    Arq Bras Oftalmol; 2015; 78(1):10-4. PubMed ID: 25714530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New treatment of age-related macular degeneration. The Danish Society of Ophthalmology].
    Bloch SB; Larsen M; Haamann P; La Cour M;
    Ugeskr Laeger; 2008 Mar; 170(12):1048. PubMed ID: 18397666
    [No Abstract]   [Full Text] [Related]  

  • 38. [Age-related macular degeneration: a socioeconomic time bomb in our aging society].
    Schrader WF
    Ophthalmologe; 2006 Sep; 103(9):742-8. PubMed ID: 16924447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Not Available].
    ; ;
    Klin Monbl Augenheilkd; 2015 Dec; 232(12):1424-7. PubMed ID: 26678907
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-VEGF therapy in neovascular age-related macular degeneration : Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Asscociation of Ophthalmologists (BVA). Stand 15.10.2022].
    ; ;
    Ophthalmologie; 2023 Feb; 120(2):169-177. PubMed ID: 36512119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.